Cyclophosphamide | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cyclophosphamide
USP

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Cyclophosphamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 21 USDMF, 6 CEP/COS, 6 EU WC, 18 NDC API, 19 Listed Suppliers, $ API Reference Price

38 API Suppliers
21 USDMF
6 CEP/COS
6 EU WC
18 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

314 Drugs in Development

314 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

135 FDF Dossiers, 77 FDA Orange Book, 15 Europe, 6 Canada, 9 Australia, 6 South Africa, 22 Listed Dossiers

135 FDF Dossiers
77 FDA Orange Book
15 Europe
6 Canada
9 Australia
6 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG, SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML), SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML), SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG
CAPSULE;ORAL - 50MG
SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML)
SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML)
SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 17 SPI Pharma, 7 DKSH, 4 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 20 Kerry, 3 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 17 Roquette, 2 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 32 Direct Compression, 18 Thickeners and Stabilizers, 17 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 14 Taste Masking, 12 Disintegrants & Superdisintegrants, 12 Granulation, 10 Coating Systems & Additives, 8 Empty Capsules, 6 Parenteral, 5 Controlled & Modified Release, 5 Film Formers & Plasticizers, 3 Emulsifying Agents, 3 Coloring Agents, 3 Topical, 2 API Stability Enhancers, 2 Solubilizers, 1 Rheology Modifiers

71 Fillers, Diluents & Binders
32 Direct Compression
18 Thickeners and Stabilizers
17 Co-Processed Excipients
16 Chewable & Orodispersible Aids
16 Lubricants & Glidants
14 Taste Masking
12 Disintegrants & Superdisintegrants
12 Granulation
10 Coating Systems & Additives
8 Empty Capsules
6 Parenteral
5 Controlled & Modified Release
5 Film Formers & Plasticizers
3 Emulsifying Agents
3 Coloring Agents
3 Topical
2 API Stability Enhancers
2 Solubilizers
1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 69 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
69 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

11 Finished Drug Prices

11 Finished Drug Prices

MARKET PLACE

14 APIs, 18 FDF Dossiers

14 APIs
18 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 5 USP, 6 Others

1 EDQM
5 USP
6 Others

$ API Ref.Price (USD/KG) : 1,094 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

5 All

01 11157002

02 11157013

03 11157024

04 11157035

05 11157046

filter Description Reset all filters

5 All

01 1Cyclophosphamide (500 mg)

02 1Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride)

03 1Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane)

04 1Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate)

05 1Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride)

filter CAS Number Reset all filters

5 All

01 11071-28-9

02 1158401-51-5

03 1158401-52-6

04 16055-19-2

05 1821-48-7

Product Main Page

01

USP

Antibody Engineering

Not Confirmed

USP

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cyclophosphamide Related Compound D (25 mg) (...

CAS Number : 158401-51-5

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1157046

Current Lot : F1I375

Previous Lot : F0I375 (31-DEC-2015)

NDC Code :

Product Web Link

Digital Content

02

USP

Antibody Engineering

Not Confirmed

USP

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cyclophosphamide Related Compound C (25 mg) (...

CAS Number : 1071-28-9

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1157035

Current Lot : R052B0

Previous Lot : F1I382 (31-AUG-2017)

NDC Code :

Product Web Link

Digital Content

03

USP

Antibody Engineering

Not Confirmed

USP

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cyclophosphamide Related Compound B (25 mg) (...

CAS Number : 158401-52-6

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1157024

Current Lot : F1I381

Previous Lot : F0I381 (31-DEC-2015)

NDC Code :

Product Web Link

Digital Content

04

USP

Antibody Engineering

Not Confirmed

USP

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cyclophosphamide Related Compound A (25 mg) (...

CAS Number : 821-48-7

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1157013

Current Lot : F1I380

Previous Lot : F0I380 (31-MAR-2017)

NDC Code :

Product Web Link

Digital Content

05

USP

Antibody Engineering

Not Confirmed

USP

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cyclophosphamide (500 mg)

CAS Number : 6055-19-2

Quantity Per Vial :

Price ($) : 185

Catalog Number : 1157002

Current Lot : R075X0

Previous Lot : R01530 (31-MAR-2018)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?